Showing results (71-80 of 118) with videos related to
Sort By:
Pageof 12
Obesity Surgery|July 22, 2021
Lisdexamfetamine Pharmacokinetic Comparison Between Patients Who Underwent Roux-en-Y Gastric Bypass and Nonsurgical ControlsKristine J Steffen, Afroz S Mohammad, James L Roerig, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 10, 2021
Factors Influencing Luciferase-Based Bioluminescent Imaging in Preclinical Models of Brain TumorMinjee Kim, Shiv K Gupta, Wenjuan Zhang, et al.Journal of Neurosurgery. Pediatrics|May 2, 2020
High-dose MTX110 (soluble panobinostat) safely administered into the fourth ventricle in a nonhuman primate modelDavid I Sandberg, Natasha Kharas, Bangning Yu, et al.The Journal of Pharmacology and Experimental Therapeutics|September 24, 2021
Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of GlioblastomaSurabhi Talele, Wenjuan Zhang, Danielle M Burgenske, et al.Melanoma Research|November 27, 2014
Impact of BRAF mutation and BRAF inhibition on melanoma brain metastasesTulasi Gummadi, Ben Y Zhang, Sara Valpione, et al.Molecular Cancer Therapeutics|October 13, 2023
Delivery versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in GlioblastomaWenjuan Zhang, Rachael A Vaubel, Ju-Hee Oh, et al.The Journal of Pharmacology and Experimental Therapeutics|October 19, 2021
Central Nervous System Distribution of an Opioid Agonist Combination with Synergistic ActivityJessica I Griffith, Minjee Kim, Daniel J Bruce, et al.Neuro-Oncology Advances|May 2, 2023
Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence timeErica A Power, Julian S Rechberger, Liang Zhang, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 15, 2023
Altering distribution profile of palbociclib by its prodrugsJuulia Järvinen, Ahmed B Montaser, Santosh Kumar Adla, et al.The Journal of Pharmacology and Experimental Therapeutics|June 10, 2024
Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain TumorsSneha Rathi, Ju-Hee Oh, Wenjuan Zhang, et al.Pageof 12